drugset / Trial / NCT02278965

Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

NCT02278965

Phase 1 Completed 19 enrolled Katherine D. Crew
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether it is feasible to give a combination of Metformin and omega-3 fatty acids for one year to women with a history of early stage breast cancer. We will also evaluate whether the metformin and omega-3 fatty acids combination causes changes in breast tissue, blood, and mammograms.

Timeline

Start
2015-01-22
Primary completion
2017-04-19
Completion
2017-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral
Subject Omega-3 fatty acids Unknown 1120 mg Oral